110 related articles for article (PubMed ID: 22042470)
1. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma.
Ribero D; Amisano M; Lo Tesoriere R; Rosso S; Ferrero A; Capussotti L
Ann Surg; 2011 Nov; 254(5):776-81; discussion 781-3. PubMed ID: 22042470
[TBL] [Abstract][Full Text] [Related]
2. Role of caudate lobectomy in type III A and III B hilar cholangiocarcinoma: a 15-year experience in a tertiary institution.
Kow AW; Wook CD; Song SC; Kim WS; Kim MJ; Park HJ; Heo JS; Choi SH
World J Surg; 2012 May; 36(5):1112-1121. PubMed ID: 22374541
[TBL] [Abstract][Full Text] [Related]
3. Impact of Biliary Drainage on Multidetector-Row Computed Tomography on R0 Resection of Perihilar Cholangiocarcinoma.
Hosokawa I; Shimizu H; Yoshitomi H; Furukawa K; Takayashiki T; Miyazaki M; Ohtsuka M
World J Surg; 2018 Nov; 42(11):3676-3684. PubMed ID: 29752510
[TBL] [Abstract][Full Text] [Related]
4. An assessment of risk factors for recurrence and survival for patients undergoing liver resection for intrahepatic cholangiocarcinoma.
Öztürk NB; Jamil LH
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):766-774. PubMed ID: 38683193
[TBL] [Abstract][Full Text] [Related]
5. How to Determine Unresectability in Hilar Cholangiocarcinoma.
Pratt CG; Whitrock JN; Shah SA; Fong ZV
Surg Clin North Am; 2024 Feb; 104(1):197-214. PubMed ID: 37953036
[TBL] [Abstract][Full Text] [Related]
6. The significance of resection margins on R0 results in intrahepatic cholangiocarcinoma.
Stüben BO; Ahmadi S; Saner FH; Li J; Neuhaus JP; Treckmann JW; Hoyer DP
Surg Oncol; 2024 Apr; 53():102058. PubMed ID: 38431994
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional visualization and evaluation of hilar cholangiocarcinoma resectability and proposal of a new classification.
Zhang JZ; Yang CX; Gao S; Bu JF; Li QQ; Wang HL; Yang KN; Tong SS; Qian LJ; Zhang J; Hua R; Sun YW; Yan JY; Chen W
World J Surg Oncol; 2023 Aug; 21(1):239. PubMed ID: 37542314
[TBL] [Abstract][Full Text] [Related]
8. A surgical strategy for intrahepatic cholangiocarcinoma - the hilar first concept.
Nevermann N; Bode J; Vischer M; Feldbrügge L; Knitter S; Krenzien F; Pelzer U; Fehrenbach U; Auer TA; Lurje G; Schmelzle M; Pratschke J; Schöning W
Langenbecks Arch Surg; 2023 Aug; 408(1):296. PubMed ID: 37544932
[TBL] [Abstract][Full Text] [Related]
9. ASO Author Reflections: Long-Term Outcomes and Optimal Margin Width Among Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma.
Alaimo L; Moazzam Z; Pawlik TM
Ann Surg Oncol; 2023 Jul; 30(7):4302-4303. PubMed ID: 36964330
[No Abstract] [Full Text] [Related]
10. The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma.
Palloni A; Bisello S; Maggio I; Massucci M; Galuppi A; Di Federico A; Rizzo A; Ricci AD; Siepe G; Morganti AG; Brandi G; Frega G
Curr Oncol; 2023 May; 30(5):4754-4766. PubMed ID: 37232816
[TBL] [Abstract][Full Text] [Related]
11. Surgical resection criteria and neoadjuvant therapies for intrahepatic cholangiocarcinoma.
O'Bryan J; Sadagopan N; Winslow E; Radkani P; Fishbein T; Banovac F; Cohen E; Hartley ML; He AR
Clin Adv Hematol Oncol; 2023 Nov; 21(11):584-591. PubMed ID: 37948594
[TBL] [Abstract][Full Text] [Related]
12. Different Oncologic Outcomes According to Margin Status (High-Grade Dysplasia vs. Carcinoma) in Patients Who Underwent Hilar Resection for Mid-Bile Duct Cancer.
Alramadhan HJ; Lim SY; Jeong HJ; Jeon HJ; Chae H; Yoon SJ; Shin SH; Han IW; Heo JS; Kim H
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958339
[TBL] [Abstract][Full Text] [Related]
13. Survival Comparison of Different Operation Types for Middle Bile Duct Cancer: Bile Duct Resection versus Pancreaticoduodenectomy Considering Complications and Adjuvant Treatment Effects.
Lim SY; Alramadhan HJ; Jeong H; Chae H; Kim HS; Yoon SJ; Shin SH; Han IW; Heo JS; Kim H
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254787
[TBL] [Abstract][Full Text] [Related]
14. Impact of Surgical Margin Status on Survival and Recurrence After Pancreaticoduodenectomy for Distal Cholangiocarcinoma: Is Microscopic Residual Tumor (R1) Associated with Higher Rates of Local Recurrence?
Umino R; Nara S; Mizui T; Takamoto T; Ban D; Esaki M; Hiraoka N; Shimada K
Ann Surg Oncol; 2024 Apr; ():. PubMed ID: 38679686
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography combined with convolutional neural networks can differentiate between intrahepatic cholangiocarcinoma and liver parenchyma ex vivo.
Wolff LI; Hachgenei E; Goßmann P; Druzenko M; Frye M; König N; Schmitt RH; Chrysos A; Jöchle K; Truhn D; Kather JN; Lambertz A; Gaisa NT; Jonigk D; Ulmer TF; Neumann UP; Lang SA; Amygdalos I
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7877-7885. PubMed ID: 37046121
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of peritoneal washing cytology in patients with biliary tract cancer.
Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Baba K; Harada T; Serikawa M; Ishii Y; Nakamura S; Arihiro K; Murakami Y; Takahashi S
Langenbecks Arch Surg; 2024 Jan; 409(1):45. PubMed ID: 38252293
[TBL] [Abstract][Full Text] [Related]
17. High-grade dysplasia of the cystic duct margin: how should this be managed?
Andersen LM; Goh IY; Siriwardhane M
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38081746
[TBL] [Abstract][Full Text] [Related]
18. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
[TBL] [Abstract][Full Text] [Related]
19. Prognosis and Circumferential Margin in Patients with Resected Hilar Cholangiocarcinoma.
Stremitzer S; Stift J; Laengle J; Schwarz C; Kaczirek K; Jones RP; Quinn LM; Fenwick SW; Diaz-Nieto R; Poston GJ; Malik HZ
Ann Surg Oncol; 2021 Mar; 28(3):1493-1498. PubMed ID: 32914390
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma.
Zhang XF; Squires MH; Bagante F; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Weiss M; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
Ann Surg Oncol; 2018 May; 25(5):1140-1149. PubMed ID: 29470820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
